{"id":"https://openalex.org/W7125156458","doi":"https://doi.org/10.1158/1538-7445.prostateca26-ia005","title":"Abstract IA005: Defining the Extracellular Vesicle Proteome of Metastatic Castration Resistant Prostate Cancer Patients treated with 177Lu-PSMA-617","display_name":"Abstract IA005: Defining the Extracellular Vesicle Proteome of Metastatic Castration Resistant Prostate Cancer Patients treated with 177Lu-PSMA-617","publication_year":2026,"publication_date":"2026-01-20","ids":{"openalex":"https://openalex.org/W7125156458","doi":"https://doi.org/10.1158/1538-7445.prostateca26-ia005"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.prostateca26-ia005","doi":"https://doi.org/10.1158/1538-7445.prostateca26-ia005","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.prostateca26-ia005","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036992928","display_name":"Justin H. Hwang","orcid":"https://orcid.org/0000-0003-1686-7103","observed_orcids":["https://orcid.org/0000-0003-1686-7103"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]},{"id":"https://openalex.org/I4390039358","display_name":"Masonic Cancer Center","ror":"https://ror.org/05x083d20","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin H. Hwang","raw_affiliation_strings":["1Division of Hematology, Oncology and Transplantation, Masonic Cancer Center, University of Minnesota Twin Cities, Minneapolis, MN,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Hematology, Oncology and Transplantation, Masonic Cancer Center, University of Minnesota Twin Cities, Minneapolis, MN,","institution_ids":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045552814","display_name":"Ali T. Arafa","orcid":"https://orcid.org/0000-0003-0460-3039","observed_orcids":["https://orcid.org/0000-0003-0460-3039"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ali T. Arafa","raw_affiliation_strings":["2Department of Pharmacology, University of Minnesota, Minneapolis, MN,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Pharmacology, University of Minnesota, Minneapolis, MN,","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122827002","display_name":"Ella Boytim","orcid":"https://orcid.org/0009-0007-8062-6431","observed_orcids":["https://orcid.org/0009-0007-8062-6431"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ella Boytim","raw_affiliation_strings":["3Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN,","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5123455903","display_name":"Lauren Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lauren Yu","raw_affiliation_strings":["3Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN,","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014166747","display_name":"Nicholas A. Zorko","orcid":"https://orcid.org/0000-0001-7021-968X","observed_orcids":["https://orcid.org/0000-0001-7021-968X"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]},{"id":"https://openalex.org/I4390039358","display_name":"Masonic Cancer Center","ror":"https://ror.org/05x083d20","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas Zorko","raw_affiliation_strings":["1Division of Hematology, Oncology and Transplantation, Masonic Cancer Center, University of Minnesota Twin Cities, Minneapolis, MN,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Hematology, Oncology and Transplantation, Masonic Cancer Center, University of Minnesota Twin Cities, Minneapolis, MN,","institution_ids":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069985314","display_name":"Scott M. Dehm","orcid":"https://orcid.org/0000-0002-7827-5579","observed_orcids":["https://orcid.org/0000-0002-7827-5579"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott M. Dehm","raw_affiliation_strings":["4Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN,","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033796700","display_name":"Justin M. Drake","orcid":"https://orcid.org/0000-0002-8329-7748","observed_orcids":["https://orcid.org/0000-0002-8329-7748"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin M. Drake","raw_affiliation_strings":["5Department of Pharmacology, University of Minnesota and Astrin Biosciences, Minneapolis, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Pharmacology, University of Minnesota and Astrin Biosciences, Minneapolis, MN","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018645768","display_name":"Emmanuel S. Antonarakis","orcid":"https://orcid.org/0000-0003-0031-9655","observed_orcids":["https://orcid.org/0000-0003-0031-9655","https://orcid.org/0000-0003-3531-3851"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]},{"id":"https://openalex.org/I4390039358","display_name":"Masonic Cancer Center","ror":"https://ror.org/05x083d20","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emmanuel S. Antonarakis","raw_affiliation_strings":["1Division of Hematology, Oncology and Transplantation, Masonic Cancer Center, University of Minnesota Twin Cities, Minneapolis, MN,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Hematology, Oncology and Transplantation, Masonic Cancer Center, University of Minnesota Twin Cities, Minneapolis, MN,","institution_ids":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"86","issue":"2_Supplement","first_page":"IA005","last_page":"IA005"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10773","display_name":"Extracellular vesicles in disease","score":0.9599999785423279,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10773","display_name":"Extracellular vesicles in disease","score":0.9599999785423279,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.0272000003606081,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10519","display_name":"Advanced Proteomics Techniques and Applications","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.8960000276565552},{"id":"https://openalex.org/keywords/extracellular-vesicles","display_name":"extracellular vesicles","score":0.9240000247955322},{"id":"https://openalex.org/keywords/ev-proteome","display_name":"EV proteome","score":0.7369999885559082},{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.7059999704360962},{"id":"https://openalex.org/keywords/177lu-lu-psma-617","display_name":"177Lu-PSMA-617","score":0.968999981880188},{"id":"https://openalex.org/keywords/psma-targeted-therapy","display_name":"PSMA-targeted therapy","score":0.6589999794960022},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.6470000147819519},{"id":"https://openalex.org/keywords/trop2","display_name":"TROP2","score":0.7720000147819519},{"id":"https://openalex.org/keywords/steap1","display_name":"STEAP1","score":0.9449999928474426},{"id":"https://openalex.org/keywords/b7-h3","display_name":"B7-H3","score":0.9670000076293945},{"id":"https://openalex.org/keywords/immune-checkpoint-proteins","display_name":"immune checkpoint molecules","score":0.6340000033378601},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8330000042915344},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6940000057220459},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.5770000219345093},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8989999890327454},{"id":"https://openalex.org/keywords/plasma-biomarkers","display_name":"plasma biomarkers","score":0.38600000739097595}],"concepts":[{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.8726999759674072},{"id":"https://openalex.org/C2908689518","wikidata":"https://www.wikidata.org/wiki/Q21097485","display_name":"Extracellular vesicle","level":5,"score":0.76910001039505},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7184000015258789},{"id":"https://openalex.org/C104397665","wikidata":"https://www.wikidata.org/wiki/Q860947","display_name":"Proteome","level":2,"score":0.5910999774932861},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5516999959945679},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48910000920295715},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.4724999964237213},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.45080000162124634},{"id":"https://openalex.org/C20518536","wikidata":"https://www.wikidata.org/wiki/Q6840469","display_name":"Microvesicles","level":4,"score":0.4361000061035156},{"id":"https://openalex.org/C2992929900","wikidata":"https://www.wikidata.org/wiki/Q21097485","display_name":"Extracellular vesicles","level":2,"score":0.3776000142097473},{"id":"https://openalex.org/C61238886","wikidata":"https://www.wikidata.org/wiki/Q5121689","display_name":"Circulating tumor cell","level":4,"score":0.36169999837875366},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.3379000127315521},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.335099995136261},{"id":"https://openalex.org/C2781261824","wikidata":"https://www.wikidata.org/wiki/Q903634","display_name":"Exosome","level":5,"score":0.3345000147819519},{"id":"https://openalex.org/C2779529041","wikidata":"https://www.wikidata.org/wiki/Q22349364","display_name":"Liquid biopsy","level":3,"score":0.31049999594688416},{"id":"https://openalex.org/C46111723","wikidata":"https://www.wikidata.org/wiki/Q471857","display_name":"Proteomics","level":3,"score":0.3093000054359436},{"id":"https://openalex.org/C157585117","wikidata":"https://www.wikidata.org/wiki/Q158666","display_name":"Omics","level":2,"score":0.2892000079154968},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.2890999913215637},{"id":"https://openalex.org/C146543888","wikidata":"https://www.wikidata.org/wiki/Q425056","display_name":"Blood proteins","level":2,"score":0.2858999967575073},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.2831999957561493},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.28299999237060547},{"id":"https://openalex.org/C2781406297","wikidata":"https://www.wikidata.org/wiki/Q409450","display_name":"Prostate-specific antigen","level":4,"score":0.2793000042438507},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.27900001406669617},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.2743000090122223},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.27390000224113464},{"id":"https://openalex.org/C2778971682","wikidata":"https://www.wikidata.org/wiki/Q412963","display_name":"Cabazitaxel","level":5,"score":0.27239999175071716},{"id":"https://openalex.org/C2775832370","wikidata":"https://www.wikidata.org/wiki/Q27888393","display_name":"Abiraterone acetate","level":5,"score":0.26660001277923584},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.2653000056743622},{"id":"https://openalex.org/C2777002142","wikidata":"https://www.wikidata.org/wiki/Q5031432","display_name":"Cancer biomarkers","level":3,"score":0.26080000400543213},{"id":"https://openalex.org/C2909763251","wikidata":"https://www.wikidata.org/wiki/Q6840469","display_name":"Microvesicle","level":5,"score":0.2574999928474426}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.prostateca26-ia005","doi":"https://doi.org/10.1158/1538-7445.prostateca26-ia005","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.prostateca26-ia005","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.45338091254234314}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Abstract":[0],"Significance.":[1],"Liquid":[2],"biopsies":[3],"from":[4,44,132,197,205,217],"patients":[5,49,178,199,219],"with":[6,51,269,290,307,366,468],"metastatic":[7,105],"castration":[8],"resistant":[9],"prostate":[10,134,226],"cancer":[11,135,227],"(mCRPC)":[12],"offer":[13],"a":[14,33,127,308,403],"dynamic":[15],"approach":[16],"to":[17,66,163,326,339,428],"assess":[18],"temporal":[19],"changes":[20],"in":[21,195,203,214,275,478,482],"the":[22,62,68,215,318,324,337,381,417,456,474],"tumor":[23,100],"genome,":[24],"transcriptome,":[25],"and":[26,78,92,109,153,167,182,200,220,234,273,314,330,343,359,422,486],"proteome.":[27],"In":[28,172,236],"this":[29,173],"study,":[30],"we":[31,130,238,244,293],"deployed":[32,401],"first-in-class":[34],"extracellular":[35],"vesicle":[36],"(EV)":[37],"proteomic":[38,71],"assay":[39,405,421],"(PMID:":[40],"39766159)":[41],"using":[42,149],"plasma":[43,64,115,397],"100":[45],"prospectively":[46],"enrolled":[47],"mCRPC":[48,69,174,198,218,276,298,412,426],"treated":[50,467],"177Lu-PSMA-617":[52,469],"as":[53,55,230,246,402],"well":[54],"20":[56],"healthy":[57,206],"male":[58],"controls.":[59,207],"We":[60],"interrogated":[61],"baseline":[63,97,301],"samples":[65],"establish":[67],"EV":[70,116,282],"landscape,":[72],"understand":[73],"biological":[74,408],"mechanisms":[75],"of":[76,177,281,310,320,383,419,460,473],"response/resistance,":[77],"inform":[79],"patient":[80,430],"outcomes":[81],"based":[82,125],"on":[83,126,295],"progression":[84],"free":[85],"or":[86,187,255,287,388],"overall":[87],"survival":[88,110],"(PFS,":[89],"OS).":[90],"Patients":[91,466],"Methods.":[93],"Clinical":[94],"variables":[95],"included":[96,224],"PSA,":[98],"molecular":[99],"volume":[101],"(MTV),":[102],"PSA50":[103,349,368,379,392],"response,":[104,292,350],"sites,":[106],"previous":[107],"therapies,":[108],"over":[111],"12":[112],"months.":[113],"The":[114],"proteome":[117],"was":[118,161],"determined":[119],"through":[120],"data-independent":[121],"acquisition":[122],"mass-spectrometry":[123],"(DIA-MS)":[124],"spectral":[128],"library":[129],"established":[131],"prior":[133],"studies,":[136],"which":[137],"accounted":[138],"for":[139,169,312,316,328,332,341,345],">6000":[140],"unique":[141],"proteins.":[142],"Statistical":[143],"analyses":[144],"(HR,":[145],"OR)":[146],"were":[147,211,288,364],"performed":[148],"Cox":[150],"proportional":[151],"hazards":[152],"logistical":[154],"regression":[155],"models.":[156],"Harrell\u2019s":[157],"bootstrap":[158],"optimism":[159],"method":[160],"used":[162],"derive":[164],"optimism-corrected":[165],"C-indices":[166],"AUC":[168],"outcomes.":[170],"Results.":[171],"cohort,":[175],"91%":[176],"had":[179,184],"bone":[180],"metastasis,":[181],"72%":[183],"received":[185],"3":[186],"more":[188],"systemic":[189],"therapies.":[190],"DIA-MS":[191],"identified":[192],"5,137":[193],"proteins":[194,202,210,228,248,283],"EVs":[196,204,216,322],"3,958":[201],"Notably,":[208],">1500":[209],"exclusively":[212],"detected":[213],"further":[221],"evaluated.":[222],"This":[223],"expected":[225],"such":[229],"PSMA,":[231,270],"TMPRSS2,":[232],"KLK2/3,":[233],"EPCAM.":[235],"addition,":[237],"found":[239],"druggable":[240],"therapeutic":[241],"targets":[242,258],"that":[243,279,354,406],"categorized":[245],"cell-surface":[247],"(HER2,":[249],"Trop-2,":[250,271],"STEAP1),":[251],"kinases":[252],"(PIK3CA,":[253],"CDK6),":[254],"immune":[256],"checkpoint":[257],"(PD-L1,":[259],"B7-H3,":[260],"CD47).":[261],"Surprisingly,":[262],"HER2":[263],"expression":[264],"exhibited":[265,284,303],"robust":[266],"positive":[267],"correlations":[268],"STEAP1":[272],"B7-H3":[274,321,355,385],"patients.":[277,413],"Given":[278],"suites":[280],"prognostic":[285,305],"value":[286],"associated":[289,365],"treatment":[291],"focused":[294],"modeling":[296],"key":[297],"targets.":[299],"While":[300],"PSA":[302,371],"modest":[304],"discrimination":[306,374],"C-index":[309,325,338],"0.518":[311],"PFS":[313,329,342],"0.619":[315],"OS,":[317],"addition":[319,382],"improved":[323],"0.625":[327],"0.694":[331],"OS.":[333,346],"Trop-2":[334,360,389],"similarly":[335],"increased":[336],"0.611":[340],"0.657":[344],"When":[347],"considering":[348],"multivariate":[351],"analysis":[352],"indicated":[353],"(OR:":[356,361],"0.292,":[357],"p=0.032)":[358],"0.146,":[362],"p=0.002)":[363],"reduced":[367],"response.":[369,380],"Baseline":[370],"demonstrated":[372],"weak":[373],"(AUC:":[375,386],"0.578)":[376],"at":[377],"predicting":[378],"either":[384],"0.648)":[387],"(AUC:0.705)":[390],"enhanced":[391],"response":[393],"prediction.":[394],"Conclusions.":[395],"Altogether,":[396],"EV-proteomics":[398],"can":[399],"be":[400],"non-invasive":[404],"provides":[407],"insights":[409],"into":[410,424],"advanced":[411],"Our":[414],"study":[415],"supports":[416],"integration":[418],"our":[420],"models":[423],"biomarker-driven":[425],"trials":[427],"improve":[429],"stratification.":[431],"Citation":[432],"Format:":[433],"Justin":[434,449],"H.":[435],"Hwang,":[436],"Ali":[437],"T.":[438],"Arafa,":[439],"Ella":[440],"Boytim,":[441],"Lauren":[442],"Yu,":[443],"Nicholas":[444],"Zorko,":[445],"Scott":[446],"M.":[447,450],"Dehm,":[448],"Drake,":[451],"Emmanuel":[452],"S.":[453],"Antonarakis.":[454],"Defining":[455],"Extracellular":[457],"Vesicle":[458],"Proteome":[459],"Metastatic":[461],"Castration":[462],"Resistant":[463],"Prostate":[464,483],"Cancer":[465,479,484,496],"[abstract].":[470],"In:":[471],"Proceedings":[472],"AACR":[475],"Special":[476],"Conference":[477],"Research:":[480],"Innovations":[481],"Research":[485],"Treatment;":[487],"2026":[488],"Jan":[489],"20-22;":[490],"Philadelphia":[491,493],"PA.":[492],"(PA):":[494],"AACR;":[495],"Res":[497],"2026;86(2_Suppl):Abstract":[498],"nr":[499],"IA005.":[500]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2026-01-22T00:00:00"}